Mucoepidermoid Carcinoma Treatment In Delhi, India

Mucoepidermoid carcinoma (MEC) is a type of cancer that commonly affects the salivary glands, though it can also occur in other areas of the body, such as the throat or wind pipe. It develops from the mucus-producing cells and the epidermal cells, which are found in various glands. The tumour can vary in aggressiveness, with some cases being slow-growing and others more aggressive. Early detection and treatment are crucial for improving outcomes and preventing the cancer from spreading. Treatment typically involves surgery, and in some cases, radiation or chemotherapy may be recommended.

Mucoepidermoid carcinoma occurs when cells in the salivary glands or other areas of the body undergo mutations and start growing uncontrollably. The specific mutations responsible for MEC are still being researched.

The exact cause of mucoepidermoid carcinoma (MEC) is not fully understood, but certain factors may increase the likelihood of developing this type of cancer:

• Radiation Exposure: Previous exposure to radiation, particularly around the head and neck, can increase the risk of developing MEC.
• Age: MEC can occur at any age, but it is more commonly diagnosed in adults, particularly between the ages of 40 and 60.
• Chronic Inflammation or Infection: Conditions that cause long-term irritation or inflammation in the salivary glands may increase the risk of cancer development.
• Genetic Factors: While rare, some genetic conditions may increase the likelihood of developing various types of cancer, including MEC.

• Mucoepidermoid carcinoma can present with a variety of symptoms, depending on the tumour's location and size. Some common symptoms include:
• Lump or Swelling: The most noticeable symptom is often a painless lump or swelling in the mouth, jaw, or neck. This may be felt under the skin or inside the mouth.
• Pain or Discomfort: In some cases, the tumour may cause pain or discomfort, especially if it presses on surrounding tissues or nerves.
• Difficulty Eating or Swallowing: If the tumour is located near the salivary glands, it may interfere with swallowing or cause difficulty when eating.
• Changes in Speech: Tumours near the mouth or throat may affect speech, leading to slurring or difficulty speaking clearly.
• Dry Mouth: When MEC affects the salivary glands, it can lead to a decrease in saliva production, resulting in a dry mouth (xerostomia).
• Numbness or Weakness: If the tumour affects nearby nerves, it can cause numbness or weakness in the face or mouth.
• Facial Asymmetry: In some cases, the tumour may cause visible changes in the face, such as asymmetry or a distorted appearance.
• Difficulty Moving the Jaw: If the tumour is located in the jaw or near the temporomandibular joint (TMJ), it may cause limited jaw movement or discomfort when opening the mouth.

Diagnosing mucoepidermoid carcinoma typically involves a combination of physical exams, imaging tests, and a biopsy. Here's an overview of the diagnostic process:

Physical Exam

The first step in diagnosing mucoepidermoid carcinoma is a thorough physical examination, where the doctor will check for any unusual lumps or swelling in areas such as the neck, mouth, or jaw. They may also assess symptoms like changes in speech or swallowing.

Imaging Tests

Various imaging tests help determine the size, location, and spread of the tumour. These tests may include:

• Ultrasound: Ultrasound uses sound waves to create images of the inside of the body. It helps doctors evaluate the tumour's size and location, especially if it's near the surface or in the salivary glands.
• Magnetic Resonance Imaging (MRI): An MRI uses strong magnets and radio waves to create detailed images of the body’s soft tissues. It is particularly useful for identifying the tumour's location and determining if it has spread to nearby tissues.
• Computed Tomography (CT) Scan: A CT scan provides cross-sectional images of the body and is used to assess the tumour's size and extent. It can also help identify any nearby structures that may be affected by the tumour.
• Positron Emission Tomography (PET) Scan: A PET scan uses radioactive material to detect areas of high metabolic activity, which may indicate the presence of cancer cells. It is often used to see if the cancer has spread to other parts of the body.

Biopsy

A biopsy is the most definitive test for diagnosing mucoepidermoid carcinoma. During a biopsy, a small sample of tissue from the tumour is removed and examined under a microscope. This allows doctors to confirm whether the tumour is cancerous and determine its type and grade (how aggressive it is). A biopsy can be performed through various methods, including fine needle aspiration or surgical removal, depending on the tumour's location.

Grading of mucoepidermoid carcinoma is an essential part of the diagnosis, as it helps determine the tumour's aggressiveness and guides treatment decisions. The grading system is based on the tumour's appearance under a microscope, focusing on the characteristics of the cancer cells and how closely they resemble normal cells. The grading typically divides mucoepidermoid carcinoma into three categories:

• Low-Grade Mucoepidermoid Carcinoma: In low-grade mucoepidermoid carcinoma, the cancer cells appear more similar to normal cells. The tumour tends to grow slowly and is less likely to spread (metastasize). Patients with low-grade tumours generally have a better prognosis and may not require aggressive treatment.
• Intermediate-Grade Mucoepidermoid Carcinoma: Intermediate-grade tumours show a mixture of well-differentiated and poorly differentiated cells. These tumours may grow more quickly than low-grade tumours and have a higher chance of spreading. Treatment for intermediate-grade tumours typically involves surgery and may include additional therapies like radiation.
• High-Grade Mucoepidermoid Carcinoma: High-grade mucoepidermoid carcinoma is characterised by poorly differentiated cancer cells that look very different from normal cells. These tumours tend to grow rapidly, are more likely to spread to other parts of the body, and have a poorer prognosis. High-grade tumours often require a combination of treatments, including surgery, radiation, and sometimes chemotherapy.

Treatment options for mucoepidermoid carcinoma include surgery, radiation therapy, chemotherapy, and targeted therapy. These treatments may be used alone or in combination, depending on the specific case.

Surgery

Surgery is the most common and effective treatment for mucoepidermoid carcinoma, especially for tumours that have not spread to other parts of the body. The goal of surgery is to remove the tumour completely. In cases where the tumour is located in the salivary glands, surgery may involve removing the affected gland or a portion of it. For tumours in the head or neck area, surgery may also involve removing nearby tissues to ensure all cancer cells are eliminated.

Radiation Therapy

Radiation therapy uses high-energy rays to kill cancer cells or shrink tumours. It is often recommended for patients with intermediate- or high-grade mucoepidermoid carcinoma or for those whose tumours cannot be completely removed through surgery. Radiation therapy can also be used after surgery in high grade/stage tumours to reduce the risk of recurrence.

Chemotherapy

Chemotherapy involves the use of drugs to kill cancer cells or prevent them from growing. This treatment is generally used for high-grade mucoepidermoid carcinoma or for tumours that have spread to other parts of the body (metastasised). Chemotherapy is often administered after surgery or radiation therapy, or it may be used when the cancer is not responding to other treatments.

Targeted Therapy

Targeted therapy involves the use of drugs that specifically target and attack cancer cells while causing less damage to normal cells. These drugs work by targeting specific molecules or proteins involved in the growth and spread of cancer. Targeted therapy is usually considered when other treatments are not effective or when the cancer has advanced.

While mucoepidermoid carcinoma is treatable, there are potential complications that may arise during treatment or after diagnosis. These complications can vary depending on the tumour’s location, grade, and the type of treatment used. Some common complications include:

• Recurrence of Cancer: Even after successful treatment, there is a possibility that the mucoepidermoid carcinoma may return, especially if it was a high-grade tumour or if not all cancer cells were removed during surgery.
• Damage to Surrounding Tissues: Surgery, especially in the head and neck areas, can sometimes result in damage to nearby tissues such as nerves, muscles, or blood vessels. This may lead to temporary or permanent side effects such as difficulty speaking, swallowing, or facial paralysis.
• Infection: As with any surgical procedure, there is a risk of infection following surgery. Wound infections or infections in the mouth or throat may require additional treatment, including antibiotics.
• Side Effects of Chemotherapy or Radiation: Chemotherapy and radiation therapy can cause a range of side effects such as nausea, fatigue, hair loss, or skin irritation.

Mucoepidermoid carcinoma cannot always be prevented but certain measures may help reduce the risk:

• Avoid Tobacco and Alcohol: Smoking and heavy alcohol use increase the risk of cancers in the head and neck region. Quitting smoking and reducing alcohol intake can lower this risk.
• Protect from Occupational Hazards: People working with harmful chemicals should follow safety guidelines to reduce exposure, as certain chemicals can increase the risk of mucoepidermoid carcinoma.
• Regular Check-Ups: Routine check-ups can help detect early symptoms of mucoepidermoid carcinoma, especially for those at higher risk.
• Good Oral Hygiene: Maintaining good oral hygiene with regular brushing, flossing, and dental check-ups can help detect early signs of issues in the mouth and throat.

1. Can mucoepidermoid carcinoma spread to other parts of the body?

Mucoepidermoid carcinoma can spread (metastasize) to other parts of the body, especially if it is a high-grade tumour.

2. How is mucoepidermoid carcinoma different from other types of head and neck cancers?

Mucoepidermoid carcinoma is a type of cancer that develops in the salivary glands or other areas of the head and neck, and it has distinct characteristics that differentiate it from other cancers, such as its cell composition and growth patterns.

3. Is mucoepidermoid carcinoma more common in certain age groups?

Mucoepidermoid carcinoma can affect people of any age, but it is more commonly diagnosed in adults, particularly those between the ages of 40 and 60. However, it can also occur in children.

4. What is the recovery time after surgery for mucoepidermoid carcinoma?

Recovery time after surgery varies based on the extent of the surgery and the individual’s health. Most patients can return to normal activities within a few weeks, but it may take several months for full recovery, especially if reconstructive surgery is required.

5. Can mucoepidermoid carcinoma cause pain or discomfort?

In some cases, mucoepidermoid carcinoma may cause pain or discomfort, particularly if the tumour is pressing on nearby tissues or nerves. However, many patients may not experience pain until the tumour grows larger.

6. Are there any lifestyle changes needed after treatment for mucoepidermoid carcinoma?

After treatment, patients may need to make some lifestyle adjustments, particularly in regard to oral hygiene, diet, and speech or swallowing therapy. These changes help manage any side effects from treatment and support recovery.

Reviewed By Dr. Akshat Malik, Principal Consultant, Cancer Care, Surgical Oncology, Head & Neck Oncology, Robotic Surgery, 14 January 2025.